Prytime Medical Devices, Inc.


Prytime Medical Devices, Inc. is an innovative medical device company that designs, develops, and commercializes minimally invasive solutions for hemorrhage control, particularly through the use of the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) technique. The company aims to improve survival rates in trauma situations where hemorrhage is the leading cause of potentially survivable death. Prytime is committed to revolutionizing the care of severely injured patients by enabling trauma teams to gain control of life-threatening bleeding as a bridge to definitive repair.

Prytime Medical Logo

Prytime Medical Devices, Inc.

12 Upper Balcones Rd, Suite 300, Boerne, TX 78006


Patents

Vascular occlusion catheter for partial occlusion or full occlusion

2024-10-01 • US-12102330-B2

View Details

Occlusion catheter system for full or partial occlusion

2024-06-18 • US-12011172-B2

View Details

System and method for low-profile occlusion balloon catheter

2024-01-02 • US-11857737-B2

View Details

System and method for low-profile occlusion balloon catheter

2023-06-13 • US-11672951-B2

View Details

System and method for low profile occlusion balloon catheter

2022-02-22 • US-11253264-B2

View Details

Handheld multi-needle vascular access device

2020-10-20 • US-10806903-B2

View Details

What We Do

Provides clinical practice guidelines, case studies, and payment and reimbursement guidelines for the use of REBOA and related products.

Designs and develops innovative medical devices such as the ER-REBOA™ PLUS Catheter and pREBOA-PRO™ Catheter for effective hemorrhage control.

A sterile catheter designed for resuscitative endovascular balloon occlusion of the aorta, aimed at controlling hemorrhage in trauma patients.

A catheter designed for true partial REBOA, providing advanced hemorrhage control options.

A simulation trainer for arterial access and REBOA techniques, designed for training healthcare professionals.



Key People

President & Chief Executive Officer

Senior Vice President, Research and Product Development

Chief Financial Officer

Senior Vice President, Quality & Regulatory

Chief Commercialization Officer


News & Updates

Prytime Medical has announced a significant donation to support medical aid and training in Ukraine.

Prytime Medical has appointed Dr. M. Chance Spalding as the new Chief Medical Officer.

Prytime Medical's products may be covered by various patents in the U.S. and internationally, including patents for REBOA catheters and simulators.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.